Abstract
The purpose of this study was to compare the effect of two serotonergic receptor antagonists on the contractile responses mediated by 5-hydroxytryptamine (5-HT) in isolated canine coronary arteries. After removing the endothelium and blocking neuronal uptake with cocaine, the coronary artery contracted when exposed to nanomolar concentrations of 5-HT; at micromolar concentrations the amine caused relaxation. A relatively high concentration of the selective S2-serotonergic antagonist, ketanserin (10(-6) M), attenuated peak contractions caused by 5-HT by an average of only 52% and caused no significant change in sensitivity to the amine. In contrast, the antagonist behaved competitively in the canine femoral artery. Cyproheptadine (10(-6) M) also was a noncompetitive serotonergic antagonist in the coronary artery. The relatively nonselective S1- and S2-serotonergic receptor antagonist, methiothepin, competitively antagonized coronary contractions caused by 5-HT with an estimated pA2 of 8.0. The rightward shifts of coronary serotonergic contractions caused by methiothepin were not significantly different whether or not ketanserin (10(-6) M) was present in the assay to block S2-serotonergic receptors. Unlike ketanserin, methiothepin (10(-6) M) nearly abolished coronary artery contractions caused by aggregating platelets. These results indicate that serotonergic coronary contractions are resistant to S2-serotonergic blockade, and suggest that they are mediated at least in part by receptors which are different from the S2-serotonergic subtype.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|